Naringin and naringenin as inhibitors of acyl CoA-cholesterol-o-acyltransferase
US6165984A · kind A · utility
26Cited by
4References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 28, 1998 |
| Grant date | Dec 26, 2000 |
| Priority date | — |
| Expiry date | Oct 28, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23V2002/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for inhibiting the activity of acyl CoA-cholesterol-o-acyltransferase, inhibiting the accumulation of macrophage-lipid complex on the arterial endothelium, and preventing or treating hepatic diseases in a mammal comprise administering naringin or naringenin thereto.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.